Autori: Currie Graeme
| Naslov | Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22 (Meeting Abstract) |
| Autori | Siefker-Radtke Arlene O Lugowska Iwona Tupikowski Krzysztof Andric Zoran G  Rezazadeh-Kalebasty A Curigliano Giuseppe Vaena Daniel A Vogl FD Currie Graeme Abella S Kelly William Kevin
|
| Info | ANNALS OF ONCOLOGY, (2019), vol. 30 br. , Suppl. 5, str. 365-365 |
| Projekat | Rainier Therapeutics, Inc. |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | FIERCE-22: Clinical activity of vofatamab (V) a FGFR3 selective inhibitor in combination with pembrolizumab (P) in WT metastatic urothelial carcinoma, preliminary analysis. (Meeting Abstract) |
| Autori | Siefker-Radtke Arlene O Currie Graeme Abella Esteban Vaena Daniel A Kalebasty Arash Rezazadeh Curigliano Giuseppe Tupikowski Krzysztof Andric Zoran G Lugowska Iwona Kelly William Kevin
|
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2019), vol. 37 br. 15, Suppl. S, str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
